(Q53570157)

15 May 2018

title

Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA. (English)

1 reference

15 May 2018

main subject

randomized experiment

1 reference

L Rostaing

1

1 reference

15 May 2018

A Hertig

2

1 reference

15 May 2018

L Albano

3

1 reference

15 May 2018

D Anglicheau

4

1 reference

15 May 2018

A Durrbach

5

1 reference

15 May 2018

V Vuiblet

6

1 reference

15 May 2018

B Moulin

7

1 reference

15 May 2018

P Merville

8

1 reference

15 May 2018

M Hazzan

9

1 reference

15 May 2018

P Lang

10

1 reference

15 May 2018

G Touchard

11

1 reference

15 May 2018

B Hurault deLigny

12

1 reference

15 May 2018

S Quéré

13

1 reference

15 May 2018

F Di Giambattista

14

1 reference

15 May 2018

Y-C Dubois

15

1 reference

15 May 2018

E Rondeau

16

1 reference

15 May 2018

CERTITEM Study Group

17

1 reference

15 May 2018

language of work or name

English

0 references

publication date

23 March 2015

1 reference

15 May 2018

American Journal of Transplantation

published in

1 reference

15 May 2018

volume

15

1 reference

15 May 2018

issue

5

1 reference

15 May 2018

page(s)

1303-1312

1 reference

15 May 2018

Identifying specific causes of kidney allograft loss.

uses

randomized experiment

0 references

cites work

1 reference

Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus.

21 January 2018

1 reference

Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years

21 January 2018

1 reference

Early epithelial phenotypic changes predict graft fibrosis

21 January 2018

1 reference

Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients

21 January 2018

1 reference

Epithelial phenotypic changes are associated with a tubular active fibrogenic process in human renal grafts

21 January 2018

1 reference

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

21 January 2018

1 reference

Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis

21 January 2018

1 reference

Autophagy is a component of epithelial cell fate in obstructive uropathy

21 January 2018

1 reference

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

21 January 2018

1 reference

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

21 January 2018

1 reference

Mechanistic connection between inflammation and fibrosis

21 January 2018

1 reference

Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?

21 January 2018

1 reference

Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.

21 January 2018

1 reference

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

21 January 2018

1 reference

Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients

21 January 2018

1 reference

Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial

21 January 2018

1 reference

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study

21 January 2018

1 reference

Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients

21 January 2018

1 reference

Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.13132

1 reference

15 May 2018

PubMed ID

25808994

1 reference

15 May 2018